[Study of the effects of immunosuppressive agents on human islet cells in vitro]. 2005

Jin-Quan Cai, and Jian-Ming Tan, and Wei-Ping Dong, and Yu-Fei Wang, and Jian-Bo Wang
Institute of Organ Transplantation, Fuzhou General Hospital, Fuzhou 350025, China.

OBJECTIVE To investigate the effects of immunosuppressive agents on insulin secretion of human islet cells in vitro. METHODS Human islet cells were isolated by the solution of the liberase and purified by Ficoll's density gradient centrifugation and then were exposed to various concentrations of four immunosuppressive agents for 24 hr respectively. Glucose-stimulated insulin secretion during subsequent static incubation was measured using the human insulin ELISA kit. RESULTS Glucose-stimulated insulin secretion from human islet cells was significantly reduced after exposed to high concentrations of MMF and FK506 (both P < 0.05). No significant reduction in insulin secretion was observed from human islet cells after exposed to FTY720 and rapamycin (both P > 0.05). CONCLUSIONS (1) High concentrations of MMF and FK506 have deleterious effects on insulin secretion in human islet cells. Low-dose FK506 + MMF is available for clinical use. (2) FTY720 and rapamycin have no adverse effects on insulin secretion in human islet cells. FTY720 and rapamycin may become useful immunosupressants for future clinical islet allotransplantation.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D011409 Propylene Glycols Derivatives of propylene glycol (1,2-propanediol). They are used as humectants and solvents in pharmaceutical preparations. Propanediols,Glycols, Propylene
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068876 Fingolimod Hydrochloride A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS. 2-Amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride,FTY 720,FTY-720,FTY720,Fingolimod,Gilenia,Gilenya
D013110 Sphingosine An amino alcohol with a long unsaturated hydrocarbon chain. Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. (Dorland, 28th ed) 4-Sphingenine,4 Sphingenine
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous

Related Publications

Jin-Quan Cai, and Jian-Ming Tan, and Wei-Ping Dong, and Yu-Fei Wang, and Jian-Bo Wang
June 1991, Transplantation,
Jin-Quan Cai, and Jian-Ming Tan, and Wei-Ping Dong, and Yu-Fei Wang, and Jian-Bo Wang
January 2006, Cell transplantation,
Jin-Quan Cai, and Jian-Ming Tan, and Wei-Ping Dong, and Yu-Fei Wang, and Jian-Bo Wang
February 1989, Transplantation proceedings,
Jin-Quan Cai, and Jian-Ming Tan, and Wei-Ping Dong, and Yu-Fei Wang, and Jian-Bo Wang
September 2022, Transplantation proceedings,
Jin-Quan Cai, and Jian-Ming Tan, and Wei-Ping Dong, and Yu-Fei Wang, and Jian-Bo Wang
December 1970, Postgraduate medical journal,
Jin-Quan Cai, and Jian-Ming Tan, and Wei-Ping Dong, and Yu-Fei Wang, and Jian-Bo Wang
January 2013, Clinical transplantation,
Jin-Quan Cai, and Jian-Ming Tan, and Wei-Ping Dong, and Yu-Fei Wang, and Jian-Bo Wang
January 1979, Advances in experimental medicine and biology,
Jin-Quan Cai, and Jian-Ming Tan, and Wei-Ping Dong, and Yu-Fei Wang, and Jian-Bo Wang
May 2002, Calcified tissue international,
Jin-Quan Cai, and Jian-Ming Tan, and Wei-Ping Dong, and Yu-Fei Wang, and Jian-Bo Wang
October 2013, Transplantation,
Jin-Quan Cai, and Jian-Ming Tan, and Wei-Ping Dong, and Yu-Fei Wang, and Jian-Bo Wang
January 1996, Alimentary pharmacology & therapeutics,
Copied contents to your clipboard!